Successful Participation at NATCON 2024 Congress: Advancing Cancer Diagnostics in India
We are excited to share our recent experience at the NATCON Congress held in Bangalore, India, dedicated to advancing cancer care from September 26 to 29, 2024. Our participation was met with overwhelming enthusiasm as numerous surgeons visited our booth, providing us with invaluable feedback on our innovative cancer diagnostic products.
Among the highlights were our cutting-edge solutions, including:
* Cancer Diagnostic Probe (CDP)
* Gamma Probe
* Thyroid Nodule Impedance Measurement System (TN-IMS)
* Impedimetric Tumor Detection System (ITDS)
* Electrical Endoscopy Mass Detection (EEMC)
* Electro Chemo Therapy (ECT)
The positive responses we received reaffirm our commitment to enhancing cancer diagnostics in India. We are hopeful that our products will play a significant role in improving cancer detection and treatment outcomes.
Thank you to everyone who visited us at the congress. We look forward to strengthening our partnerships and continuing our mission to support cancer care in India.
